Linaclotide for the treatment of refractory lower bowel manifestations of systemic sclerosis.
Eric J DeinFredrick M WigleyZsuzsanna H McMahanPublished in: BMC gastroenterology (2021)
Linaclotide is a well-tolerated and efficacious pro-secretory and pro-motility agent that can be used to manage refractory lower GI manifestations in SSc. We found that low-dose linaclotide is an effective option and may be better tolerated, though a subset of patients may require high dose regimens.